Patent details

EN | LT

LT - UTILISATION THERAPEUTIQUE D`AU MOINS UNE NEUROTOXINE BOTULIQUE DANS LE TRAITEMENT DE LA DOULEUR INDUITE PAR AU MOINS UN AGENT ANTI-CANCEREUX

EN - THERAPEUTIC USE OF AT LEAST ONE BOTULIC NEUROTOXIN IN THE TREATMENT OF PAIN INDUCED BY AT LEAST ONE ANTINEOPLASTIC AGENT

Legal status

Patent not validated

Bibliographic data

European patent
(11)	Number of the document	2083837
(13)	Kind of document	T
(96)	European patent application number	07866446.3
	Date of filing the European patent application	2007-10-26
(97)	Date of publication of the European application	2009-08-05
(45)	Date of publication and mention of the grant of the patent	2015-01-07
(46)	Date of publication of the claims translation

PCT application
(86)	Number	PCT/FR2007/001773
	Date	2007-10-26

PCT application publication
(87)	Number	WO 2008/059126
	Date	2008-05-22

Priority applications
(30)	Number	Date	Country code
	0609435	2006-10-27	FR

Inventors
(72)	FAVRE, Christine, FR AUGUET, Michel, FR CHABRIER DE LASSAUNIERE, Pierre-Etienne, FR

Grantee
(73)	IPSEN PHARMA S.A.S., 65, Quai Georges Gorse, 92100 Boulogne-Billancourt, FR

Title
(54)	UTILISATION THERAPEUTIQUE D`AU MOINS UNE NEUROTOXINE BOTULIQUE DANS LE TRAITEMENT DE LA DOULEUR INDUITE PAR AU MOINS UN AGENT ANTI-CANCEREUX
	THERAPEUTIC USE OF AT LEAST ONE BOTULIC NEUROTOXIN IN THE TREATMENT OF PAIN INDUCED BY AT LEAST ONE ANTINEOPLASTIC AGENT